HOME >> MEDICINE >> NEWS
Omega-3 fatty acids may slow cognitive decline in some patients with very mild Alzheimer's disease

Omega-3 fatty acid supplements may slow cognitive decline in some patients with very mild Alzheimer's disease, but do not appear to affect those with more advanced cases, according to results of a clinical trial published in the October issue of Archives of Neurology, one of the JAMA/Archives journals.

Alzheimer's disease is a severely debilitating condition that affects thinking, learning and memory, beginning with declines in episodic memory (including memory about events in one's own life), according to background information in the article. Medications are available to treat the symptoms, but these drugs do not affect the underlying cause and progression of the disease. Several studies have shown that eating fish, which is high in omega-3 fatty acids, may protect against Alzheimer's disease, leading researchers to question whether supplements could have similar effects.

Yvonne Freund-Levi, M.D., Karolinska Institutet, Stockholm, Sweden, and colleagues compared the effects of supplements containing two omega-3 fatty acids with placebo in 204 patients with Alzheimer's disease, 174 of whom completed the entire study. For six months, 89 patients (51 women and 38 men) took 1.7 grams of docosahexaenoic acid (DHA) and .6 grams of eicosapentaenoic acid (EPA), while 85 patients (39 women and 46 men) took placebo. For an additional six months, both groups took the omega-3 fatty acids. Patients had physical examinations, which included blood tests and blood pressure measurement, and took cognitive tests at the beginning of the study and at the six- and 12-month marks.

After six months, there was no difference in the rate of cognitive decline between the two groups. However, among a subgroup of 32 patients with very mild cognitive impairment at the beginning of the study, those who took the fatty acids experienced less decline in six months compared with those who took placebo. Among those who took placebo during the first six months, de
'"/>

Contact: Jan Palmblad
jan.palmblad@ki.se
JAMA and Archives Journals
9-Oct-2006


Page: 1 2

Related medicine news :

1. Omega-3 fatty acids may slow down early Alzheimers in some cases
2. The nude mouse tale: Omega-3 fats save the life of a terminal cancer patient
3. Omega-3 offers hope for new anti-breast cancer drugs
4. Can an omega-3 fatty acid slow the progression of Alzheimers disease?
5. Long-term effects of non-alcoholic fatty liver disease
6. Researchers estimate significant fatty liver disease in children
7. UCLA study shows altering fatty acid levels in diet may reduce prostate cancer growth rate
8. Patients with nonalcoholic fatty liver disease have an increased risk of heart disease
9. Omega 3 fatty acids influence mood, impulsivity and personality, study indicates
10. Consumption of omega-3 fatty acids unlikely to significantly reduce risk of cancer
11. Northwestern Memorial researchers aim to find answer to halting the progression of fatty liver

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/24/2017)... ... January 23, 2017 , ... ... new plugin that allows sleep centers to automatically connect and initialize all their ... thin client browser plugin is quickly installed on first use and then monitors ...
(Date:1/23/2017)... (PRWEB) , ... January 23, 2017 , ... ... website this week at a new domain address. Alpine Springs Rehabilitation & Recovery ... has also debuted a new logo along with its redesigned and retooled website. ...
(Date:1/23/2017)... ... January 23, 2017 , ... ... life science companies, has achieved ISO 17100:2015 certification following a comprehensive audit ... is the globally recognized standard that establishes guidance for critical processes within ...
(Date:1/23/2017)... ... January 23, 2017 , ... DMG Productions is ... Ed Begley, Jr., scheduled to broadcast Saturday, January 28, 2017 at 5:00pmEST. , ... in 2008 to address the limitations of fatigue monitoring technologies within the mining ...
(Date:1/23/2017)... (PRWEB) , ... January 23, 2017 , ... Wooden and plastic balance boards have been ... and improve balance. Kumo Board is the first and only balance board to ... to be soft and rigid at the same time as well as skill-level adjustable for ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... Research and Markets has announced the addition of the ... their offering. ... The interventional radiology products market is expected to reach USD 8.02 ... CAGR of 4.8%. This market is segmented based on type, procedure, ... of this market are rising incidence of chronic diseases, rising geriatric ...
(Date:1/23/2017)... 23, 2017  Delcath Systems, Inc. (NASDAQ: ... treatment of primary and metastatic liver cancers, today announced ... President and Chief Executive Officer of Delcath will be ... Markets, Thirteenth Annual Investor Conference at the Boca Raton ... , on Tuesday, January 31, 2017 at 10:30 ...
(Date:1/23/2017)... , January 23, 2017 ... (r enal) y el riesgo ... de a pabetalone    Resverlogix Corp. ... resultados preliminares de un ensayo en fase 1 con ... de riñón (renal) severa. Los datos demostraron unos resultados ...
Breaking Medicine Technology:
Cached News: